1,2-dimethylhydrazine affects expression ISO RGD:733486 6480464 1, 2-Dimethylhydrazine affects the expression of HNRNPK mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:733486 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HNRNPK mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO RGD:733486 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HNRNPK mRNA CTD PMID:17942748 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of HNRNPK protein CTD PMID:32145629 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one decreases expression ISO RGD:733485 6480464 Metribolone results in decreased expression of HNRNPK protein CTD PMID:17152098 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:733486 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733486 6480464 Tetrachlorodibenzodioxin affects the expression of HNRNPK mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:733486 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of HNRNPK mRNA CTD PMID:17942748 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:19954255 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression EXP 6480464 2 more ... CTD PMID:19954255 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of HNRNPK mRNA CTD PMID:21346803 2-methylcholine affects expression ISO RGD:733485 6480464 beta-methylcholine affects the expression of HNRNPK mRNA CTD PMID:21179406 3',5'-cyclic UMP affects binding ISO RGD:733485 6480464 HNRNPK protein binds to cyclic 3', 5'-uridine monophosphate CTD PMID:30528433 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:733486 6480464 3 more ... CTD PMID:19467301 3-phenylprop-2-enal increases metabolic processing ISO RGD:733485 6480464 cinnamaldehyde results in increased metabolism of HNRNPK protein CTD PMID:29267982 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of HNRNPK mRNA CTD PMID:19162173 7,12-dimethyltetraphene affects expression ISO RGD:733486 6480464 9 more ... CTD PMID:21785161 aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of HNRNPK mRNA, Glucose results in decreased expression of HNRNPK protein CTD PMID:16837467 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of HNRNPK mRNA CTD PMID:16483693 ammonium chloride increases expression EXP 6480464 Ammonium Chloride results in increased expression of HNRNPK mRNA CTD PMID:12420312 antirheumatic drug decreases expression ISO RGD:733485 6480464 Antirheumatic Agents results in decreased expression of HNRNPK mRNA CTD PMID:25339124 Aroclor 1254 decreases expression ISO RGD:733486 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of HNRNPK mRNA CTD PMID:23650126 arsane decreases expression ISO RGD:733485 6480464 Arsenic results in decreased expression of HNRNPK protein CTD PMID:25110733 arsenic atom decreases expression ISO RGD:733485 6480464 Arsenic results in decreased expression of HNRNPK protein CTD PMID:25110733 arsenous acid decreases expression ISO RGD:733485 6480464 Arsenic Trioxide results in decreased expression of HNRNPK protein CTD PMID:19747914 , PMID:25419056 arsenous acid increases expression ISO RGD:733485 6480464 Arsenic Trioxide results in increased expression of HNRNPK protein CTD PMID:19364129 benzatropine multiple interactions ISO RGD:733485 6480464 [Cuprizone co-treated with Benztropine] results in decreased expression of HNRNPK protein CTD PMID:34122009 benzo[a]pyrene decreases expression ISO RGD:733485 6480464 Benzo(a)pyrene results in decreased expression of HNRNPK protein CTD PMID:20097212 benzo[a]pyrene multiple interactions ISO RGD:733485 6480464 [Soot co-treated with Benzo(a)pyrene] results in decreased expression of HNRNPK protein modified form, [Soot co-treated with Benzo(a)pyrene] results in increased expression of HNRNPK protein modified form CTD PMID:24464499 benzo[a]pyrene increases expression ISO RGD:733486 6480464 Benzo(a)pyrene results in increased expression of HNRNPK mRNA CTD PMID:20127859 , PMID:22228805 benzo[a]pyrene affects expression ISO RGD:733486 6480464 Benzo(a)pyrene affects the expression of HNRNPK mRNA CTD PMID:22342234 benzo[a]pyrene decreases expression ISO RGD:733486 6480464 Benzo(a)pyrene results in decreased expression of HNRNPK mRNA CTD PMID:22228805 bis(2-ethylhexyl) phthalate increases expression ISO RGD:733486 6480464 Diethylhexyl Phthalate results in increased expression of HNRNPK protein CTD PMID:28934723 bisphenol A multiple interactions EXP 6480464 [Fructose co-treated with bisphenol A] results in increased expression of HNRNPK protein CTD PMID:26930160 bisphenol A decreases expression ISO RGD:733485 6480464 bisphenol A results in decreased expression of HNRNPK protein CTD PMID:34186270 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of HNRNPK protein CTD PMID:20219716 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of HNRNPK mRNA, bisphenol A results in increased expression of HNRNPK protein CTD PMID:22649256 more ... Bisphenol B increases expression ISO RGD:733485 6480464 bisphenol B results in increased expression of HNRNPK protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:733485 6480464 bisphenol F results in increased expression of HNRNPK protein CTD PMID:34186270 Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of HNRNPK protein CTD PMID:28903499 bufalin decreases expression ISO RGD:733485 6480464 bufalin results in decreased expression of HNRNPK protein CTD PMID:23091618 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of HNRNPK promoter CTD PMID:22457795 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of HNRNPK mRNA CTD PMID:18636176 caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of HNRNPK mRNA CTD PMID:25868845 caffeine affects phosphorylation ISO RGD:733485 6480464 Caffeine affects the phosphorylation of HNRNPK protein CTD PMID:35688186 caffeine increases expression ISO RGD:733485 6480464 Caffeine results in increased expression of HNRNPK protein CTD PMID:31195006 cannabidiol multiple interactions ISO RGD:733485 6480464 [Cuprizone co-treated with Cannabidiol] results in decreased expression of HNRNPK protein CTD PMID:34122009 carbon nanotube affects expression ISO RGD:733485 6480464 Nanotubes, Carbon affects the expression of HNRNPK protein CTD PMID:22001959 carbon nanotube increases expression ISO RGD:733486 6480464 Nanotubes, Carbon analog results in increased expression of HNRNPK mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:733485 6480464 CGP 52608 promotes the reaction [RORA protein binds to HNRNPK gene] CTD PMID:28238834 chloromethylisothiazolinone increases metabolic processing ISO RGD:733485 6480464 5-chloro-2-methyl-4-isothiazolin-3-one results in increased metabolism of HNRNPK protein CTD PMID:29267982 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of HNRNPK mRNA CTD PMID:17602206 clothianidin decreases expression ISO RGD:733485 6480464 clothianidin results in decreased expression of HNRNPK mRNA CTD PMID:31626844 cobalt dichloride decreases expression ISO RGD:733485 6480464 cobaltous chloride results in decreased expression of HNRNPK mRNA CTD PMID:19320972 colforsin daropate hydrochloride multiple interactions EXP 6480464 Colforsin promotes the reaction [HNRNPK protein binds to SNAP25 exon] CTD PMID:22684629 copper atom affects binding ISO RGD:733485 6480464 HNRNPK protein binds to Copper CTD PMID:15359738 copper atom multiple interactions ISO RGD:733486 6480464 MT1 affects the reaction [Copper results in increased expression of HNRNPK mRNA], MT2 affects the reaction [Copper results in increased expression of HNRNPK mRNA] CTD PMID:16629173 copper(0) affects binding ISO RGD:733485 6480464 HNRNPK protein binds to Copper CTD PMID:15359738 copper(0) multiple interactions ISO RGD:733486 6480464 MT1 affects the reaction [Copper results in increased expression of HNRNPK mRNA], MT2 affects the reaction [Copper results in increased expression of HNRNPK mRNA] CTD PMID:16629173 coumarin affects phosphorylation ISO RGD:733485 6480464 coumarin affects the phosphorylation of HNRNPK protein CTD PMID:35688186 CU-O LINKAGE increases phosphorylation ISO RGD:733485 6480464 cupric oxide results in increased phosphorylation of HNRNPK protein CTD PMID:25470785 Cuprizon increases expression ISO RGD:733485 6480464 Cuprizone results in increased expression of HNRNPK protein CTD PMID:34122009 Cuprizon multiple interactions ISO RGD:733485 6480464 [Cuprizone co-treated with Benztropine] results in decreased expression of HNRNPK protein, [Cuprizone co-treated with Cannabidiol] results in decreased expression of HNRNPK protein CTD PMID:34122009 cycloheximide multiple interactions EXP 6480464 Cycloheximide inhibits the reaction [Glycine results in increased expression of HNRNPK protein] CTD PMID:24990929 cyclophosphamide increases expression ISO RGD:733485 6480464 Cyclophosphamide results in increased expression of HNRNPK protein CTD PMID:17475930 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of HNRNPK mRNA CTD PMID:11599041 D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of HNRNPK mRNA, Glucose results in decreased expression of HNRNPK protein CTD PMID:16837467 diarsenic trioxide increases expression ISO RGD:733485 6480464 Arsenic Trioxide results in increased expression of HNRNPK protein CTD PMID:19364129 diarsenic trioxide decreases expression ISO RGD:733485 6480464 Arsenic Trioxide results in decreased expression of HNRNPK protein CTD PMID:19747914 , PMID:25419056 dihydroartemisinin affects binding ISO RGD:733485 6480464 artenimol analog binds to HNRNPK protein CTD PMID:26340163 dioxygen increases expression ISO RGD:733486 6480464 Oxygen deficiency results in increased expression of HNRNPK protein CTD PMID:25937538 disodium selenite increases expression ISO RGD:733485 6480464 Sodium Selenite results in increased expression of HNRNPK mRNA CTD PMID:18175754 doxorubicin decreases expression ISO RGD:733485 6480464 Doxorubicin results in decreased expression of HNRNPK protein CTD PMID:19747914 doxorubicin decreases response to substance ISO RGD:733485 6480464 HNRNPK protein results in decreased susceptibility to Doxorubicin CTD PMID:24675091 enzyme inhibitor multiple interactions ISO RGD:733485 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of HNRNPK protein CTD PMID:23301498 ethanol increases expression ISO RGD:733485 6480464 Ethanol results in increased expression of HNRNPK protein CTD PMID:20621659 ethanol affects splicing ISO RGD:733486 6480464 Ethanol affects the splicing of HNRNPK mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:733485 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of HNRNPK mRNA CTD PMID:29432896 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of HNRNPK protein CTD PMID:33656234 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of HNRNPK mRNA CTD PMID:34044035 folic acid multiple interactions ISO RGD:733486 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of HNRNPK mRNA CTD PMID:22206623 fructose multiple interactions EXP 6480464 [Fructose co-treated with bisphenol A] results in increased expression of HNRNPK protein CTD PMID:26930160 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of HNRNPK mRNA CTD PMID:22061828 glucose decreases expression EXP 6480464 Glucose results in decreased expression of HNRNPK mRNA, Glucose results in decreased expression of HNRNPK protein CTD PMID:16837467 glycine affects localization EXP 6480464 Glycine affects the localization of HNRNPK protein CTD PMID:24990929 glycine increases expression EXP 6480464 Glycine results in increased expression of HNRNPK mRNA CTD PMID:24990929 glycine multiple interactions EXP 6480464 Cycloheximide inhibits the reaction [Glycine results in increased expression of HNRNPK protein] more ... CTD PMID:24990929 glyphosate increases expression ISO RGD:733486 6480464 glyphosate results in increased expression of HNRNPK protein CTD PMID:37208198 haloperidol decreases expression ISO RGD:733485 6480464 Haloperidol results in decreased expression of HNRNPK protein CTD PMID:34122009 hexadecanoic acid decreases phosphorylation ISO RGD:733485 6480464 Palmitic Acid results in decreased phosphorylation of HNRNPK protein CTD PMID:28073184 hyaluronic acid decreases expression EXP 6480464 Hyaluronic Acid analog results in decreased expression of HNRNPK protein CTD PMID:23178681 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of HNRNPK protein CTD PMID:23178681 isobutanol multiple interactions ISO RGD:733485 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of HNRNPK mRNA CTD PMID:29432896 ivermectin decreases expression ISO RGD:733485 6480464 Ivermectin results in decreased expression of HNRNPK protein CTD PMID:32959892 lipopolysaccharide multiple interactions ISO RGD:733485 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of HNRNPK mRNA CTD PMID:35877022 lovastatin decreases expression ISO RGD:733486 6480464 Lovastatin results in decreased expression of HNRNPK mRNA CTD PMID:20493250 lovastatin increases expression ISO RGD:733486 6480464 Lovastatin results in increased expression of HNRNPK mRNA CTD PMID:20493250 maneb multiple interactions ISO RGD:733486 6480464 [Paraquat co-treated with Maneb] results in decreased expression of HNRNPK mRNA CTD PMID:18386188 metformin multiple interactions ISO RGD:733485 6480464 [Paclitaxel co-treated with Metformin] results in decreased expression of HNRNPK mRNA CTD PMID:29309887 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of HNRNPK mRNA CTD PMID:30467583 methidathion affects expression ISO RGD:733486 6480464 methidathion affects the expression of HNRNPK mRNA CTD PMID:34813904 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:733485 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [NSC606985 results in decreased expression of HNRNPK protein], benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [PRKCD protein results in increased ubiquitination of HNRNPK protein] CTD PMID:19747914 N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of HNRNPK protein CTD PMID:19716841 nickel atom decreases expression ISO RGD:733486 6480464 Nickel results in decreased expression of HNRNPK mRNA CTD PMID:18922574 ochratoxin A decreases expression ISO RGD:733486 6480464 ochratoxin A results in decreased expression of HNRNPK protein CTD PMID:19445961 paclitaxel multiple interactions ISO RGD:733485 6480464 [Paclitaxel co-treated with Metformin] results in decreased expression of HNRNPK mRNA CTD PMID:29309887 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of HNRNPK mRNA CTD PMID:33387578 paraquat multiple interactions ISO RGD:733486 6480464 [Paraquat co-treated with Maneb] results in decreased expression of HNRNPK mRNA CTD PMID:18386188 paraquat increases expression EXP 6480464 Paraquat results in increased expression of HNRNPK mRNA CTD PMID:16328009 perfluorooctanoic acid increases expression ISO RGD:733485 6480464 perfluorooctanoic acid results in increased expression of HNRNPK protein CTD PMID:22609092 phenethyl isothiocyanate affects binding ISO RGD:733485 6480464 HNRNPK protein binds to phenethyl isothiocyanate CTD PMID:21838287 propiconazole decreases expression ISO RGD:733486 6480464 propiconazole results in decreased expression of HNRNPK mRNA CTD PMID:21278054 quartz increases expression ISO RGD:733485 6480464 Quartz results in increased expression of HNRNPK protein CTD PMID:27917503 quercetin affects phosphorylation ISO RGD:733485 6480464 Quercetin affects the phosphorylation of HNRNPK protein CTD PMID:35688186 resveratrol decreases expression ISO RGD:733486 6480464 resveratrol results in decreased expression of HNRNPK protein CTD PMID:25505154 rottlerin multiple interactions ISO RGD:733485 6480464 rottlerin inhibits the reaction [NSC606985 results in decreased expression of HNRNPK protein] CTD PMID:19747914 silicon dioxide increases expression ISO RGD:733485 6480464 Silicon Dioxide results in increased expression of HNRNPK protein CTD PMID:27917503 sodium arsenite decreases expression ISO RGD:733485 6480464 sodium arsenite results in decreased expression of HNRNPK protein CTD PMID:20050688 sodium fluoride increases expression ISO RGD:733486 6480464 Sodium Fluoride results in increased expression of HNRNPK protein CTD PMID:27548804 sodium fluoride decreases expression ISO RGD:733486 6480464 Sodium Fluoride results in decreased expression of HNRNPK mRNA CTD PMID:27862939 sulforaphane affects binding ISO RGD:733485 6480464 HNRNPK protein binds to sulforaphane CTD PMID:21838287 T-2 toxin affects expression EXP 6480464 T-2 Toxin affects the expression of HNRNPK protein CTD PMID:26141394 thapsigargin decreases expression EXP 6480464 Thapsigargin results in decreased expression of HNRNPK protein CTD PMID:35544339 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of HNRNPK mRNA CTD PMID:33387578 trichostatin A affects expression ISO RGD:733485 6480464 trichostatin A affects the expression of HNRNPK mRNA CTD PMID:28542535 triptonide decreases expression ISO RGD:733486 6480464 triptonide results in decreased expression of HNRNPK mRNA CTD PMID:33045310 valproic acid decreases methylation ISO RGD:733485 6480464 Valproic Acid results in decreased methylation of HNRNPK gene CTD PMID:29154799 valproic acid affects expression ISO RGD:733486 6480464 Valproic Acid affects the expression of HNRNPK mRNA CTD PMID:17963808 warfarin increases expression ISO RGD:733486 6480464 Warfarin results in increased expression of HNRNPK mRNA CTD PMID:20493250 warfarin decreases expression ISO RGD:733486 6480464 Warfarin results in decreased expression of HNRNPK mRNA CTD PMID:20493250 withaferin A multiple interactions ISO RGD:733485 6480464 [withanone co-treated with withaferin A] results in decreased expression of HNRNPK protein, withaferin A binds to and results in decreased activity of HNRNPK protein CTD PMID:25236891